Author/Authors :
Razzaghi, Mohammadreza Laser Application in Medical Sciences Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Asghari-azghan, Afsar Urology Department - Shohada-e-Tajrish Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Montazeri, Saeed Urology Department - Shohada-e-Tajrish Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Razzaghi, Zahra Laser Application in Medical Sciences Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Mazloomfard, Mohammad Mohsen Laser Application in Medical Sciences Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Vafaee, Reza Proteomics Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Introduction: Radiofrequency (RF)-based stress urinary incontinence (SUI) treatment, which has
quickly attracted attention, is administered in an office setting. This pilot-safety study assessed the
efficacy of transvaginal RF treatment in the quality of life (QOL) and frequency of incontinence
episodes in women with SUI.
Methods: Twenty-eight women suffering from SUI were treated with an intravaginal quadric
applicator while a grounding pad was attached in front of their pubes. The first phase is thermic,
which will heat up the vaginal wall up to 40°C for 10 minutes. The second step is contraction to
stimulate an aerobic exercise of pelvic floor muscles for 20 minutes (pulsed contractile RF at 20-40
watts and 1000-300 kHz with a modulation of 1 to 300 Hz for muscle exercise). It was scheduled
for one session per week for 3 sessions. Patients had follow-up visits before and 1, 6 and 12 months
following the treatment for one-day voiding diary, Persian version of urinary incontinence QOL
questionnaire (I-QOL), Q-tip test, 24 hours-pad test and daily incontinence episodes’ number.
Results: The patients’ mean age, duration of incontinence and median vesical leak point pressure
were 41.6±9.6 years, 5.48±6.84 years and 140 cm H2
O respectively. Significant changes were
observed in the mean I-QOL total score and the pad test. Also, a notable reduction was observed in
the number of daily leakage episodes and the Q-tip test at any follow-up visit (P=0.001).
Conclusion: Preliminary results suggest that transvaginal RF is a convenient method of SUI treatment.
Significant changes were observed in the mean I-QOL total score and the pad test. Also, a notable
reduction was observed in the number of daily leakage episodes.